Upside:
$MBX 128% (once-Weekly Canvuparatide Achieved Primary Endpoint in Phase 2 Trial with 63% Responder Rate at 12 Weeks; 79% Responder Rate at 6 Months in Open-Label Extension; Preparation underway to initiate Phase 3 trial in 2026)
$MTSR 62% (Pfizer confirms to acquire Metsera at $47.50/shr for EV of $4.9B plus possible milestone payouts of up to $22.50/shr)
$HOUS 56% (reportedly to be acquired by Compass for $1.6B)
$BKKT 41% (appoints Mike Alfred to Board of Directors)
$PRO 40% (to be acquired by PE firm Thoma Bravo at $23.25/shr cash)
$ODP 33% (to be acquired by Atlas Holdings at $28/shr in cash in ~$1.0B all-cash transaction)
$SMLR 28% (announces Bitcoin treasury merger with Strive, Inc, in all-stock transaction)
$DGNX 22% (momentum)
$IREN 9.7% (targets Q1 2026 AI Cloud ARR $500M)
$PINC 8.5% (to be acquired by Patient Square Capital at $28.25/shr cash)
$SNAP 8.5% (meme trades, TikTok deal peripherals)
$VUZI 7.0% (achieves Waveguide Production Milestones and receives additional $5M Quanta Investment)
$BLNK 6.6% (Hubject teams with Blink Charging to expand intercharge network across N.A.)
$CCO 6.4% (reportedly Activist Anson pushing company to pursue a sale)
$ACTU 6.3% (provides FDA with Updated Clinical Data Package to Support Planned Regulatory Interactions with FDA and EMA over the coming months)
$IMNN 6.2% (presents IMNN-001 Phase 2 Translational Data in Advanced Ovarian Cancer Demonstrating 13-Month OS Extension via Tumor Micro-Environment Shift)
$BBBY 5.1% (announces dividend of warrant to shareholders)
$GDYN 4.0% (Jefferies Initiates GDYN with Buy, price target: $11)
$REYN 3.2% (to be added to S&P600 Index, effective Sept 24th)
$B 2.5% (broker raises price target on Nevada mine)
$EAT 2.4% (Wells Fargo Raised EAT to Overweight from Equal Weight, price target: $175 from $165)
$FLY 2.4% (receives $10M NASA Contract Addendum for Blue Ghost Mission 1 Lunar Data)
$FOX 2.1% (reportedly considering stake in TikTok)
Downside:
$COMP -12% (confirms to merge with Anywhere Real Estate in $10B all-stock agreement)
$DFDV -4.5% (announces strategic collaboration with ZeroStack in treasury accelerator deal)
$KVUE -4.3% (weakness in anticipation of Trump Administration linking Tylenol to autism)